2022 Cancer Research Grant Recipients
Dr. Xiaoqun Dong
2022ASSISTANT PROFESSOR OF MEDICINE
BROWN UNIVERSITY
Armored TRUCK Runs Over Breast Cancer
Dr. Andrey Ivanov
2022EMORY UNIVERSITY
ASSISTANT PROFESSOR
Targeting MKK3-MYC complex to reduce racial survival disparity in breast cancer
Dr. Marikki Laiho
2022PROFESSOR OF RADIATION ONCOLOGY AND ONCOLOGY
THE JOHNS HOPKINS UNIVERSITY
Rewiring of splicing programs in endometrial and ovarian cancers by new therapeutic agents
Dr. Samuel Bakhoum
2022ASSISTANT PROFESSOR
MEMORIAL SLOAN KETTERING CANCER CENTER
Examining the link between chromosomal instability and epigenetic alterations in High-Grade Serous Ovarian Cancer
Dr. Krzysztof Geras
2022ASSISTANT PROFESSOR
NYU GROSSMAN SCHOOL OF MEDICINE
Artificial Intelligence for Multi-Modal Breast Cancer Diagnosis
Dr. Gail Matters
2022ASSOCIATE PROFESSOR OF BIOCHEMISTRY AND MOLECULAR BIOLOGY
PENN STATE COLLEGE OF MEDICINE
Detecting bone metastatic breast cancer by nanoparticle enhanced MRI
Dr. Gina Lee
2022ASSISTANT PROFESSOR
UNIVERSITY OF CALIFORNIA, IRVINE, SCHOOL OF MEDICINE
Targeting estrogen-eIF4A intersection in women’s LAM tumors
Dr. Tiffany Seagroves
2022PROFESSOR OF PATHOLOGY
THE UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER
Targeting Creatine Kinase Brain Isoform (CKB) to Improve Survival from Breast Cancer Brain Metastasis
Dr. Diego Castrillon
2022PROFESSOR, DEPARTMENT OF PATHOLOGY
UT SOUTHWESTERN MEDICAL CENTER
Understanding the Initiation of Endometrial Cancer
Dr. Priyanka Verma
2022ASSISTANT PROFESSOR OF MEDICINE
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS
Inhibition of ALC1 ATPase activity as a new synthetic lethal strategy for BRCA-mutant cancers
2021 Cancer Research Grant Recipients
Dr. Liron Bar-Peled
2021Assistant Professor
The General Hospital Corporation d/b/a Massachusetts General Hospital
Chemical Proteomic Identification of Druggable Vulnerabilities in Ovarian Cancer
Dr. Elliot Androphy
2021KAMPEN-NORINS PROFESSOR CHAIR, DEPARTMENT OF DERMATOLOGY
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Pharmacology of human papillomavirus inhibitory compounds in mice
Dr. Itai Yanai
2021Professor
NEW YORK UNIVERSITY GROSSMAN SCHOOL OF MEDICINE
Targeting treatment-resistant ovarian cancer cell states
Dr. Sandra Orsulic
2021Professor in Residence
UCLA David Geffen School of Medicine
Implantable “Tumor Trap” for Metastatic Cancer Cells
Dr. Gerald Crabtree
2021Professor
The Board of Trustees of the Leland Stanford Junior University
Hijacking the Estrogen Receptor to Activate Apoptotic Pathways in ER-Positive Breast Cancer
Dr. Karl Munger
2021PROFESSOR AND CHAIR, DEPARTMENT OF DEVELOPMENTAL, MOLECULAR AND CHEMICAL BIOLOGY
Tufts University School of Medicine
Towards Predictive Biomarkers in Cervical Cancer: Determining Carcinogenic Activities of E6 Oncogene Variants Detected in HPV16 Infected Women
Dr. Ozgur Sahin
2021Associate Professor
UNIVERSITY OF SOUTH CAROLINA College of Pharmacy
Enhancing the efficacy of antibody-drug conjugate (ADC) therapy in aggressive breast cancers
Dr. Beth Weaver
2021Associate Professor
University of Wisconsin – Madison School of Medicine & Public Health
Chromosomal instability as a marker of paclitaxel response in breast cancer
Dr. Esra Akbay
2021Assistant Professor
UT SOUTHWESTERN Medical Center
Targeting telomerase to modulate tumor immune microenvironment in endometrial cancer
Dr. Dario Altieri
2021DIRECTOR, THE WISTAR INSTITUTE CANCER CENTER
THE WISTAR INSTITUTE
Therapeutic Targeting of ILK in Breast Cancer
2020 Cancer Research Grant Recipients
Dr. Hua Yu
2020ASSOCIATE CHAIR AND PROFESSOR, DEPARTMENT OF IMMUNO-ONCOLOGY
BECKMAN RESEARCH INSTITUTE CITY OF HOPE
The opposing roles of PARP and PARG inhibitors in regulating ovarian cancer immune responses.
Dr. Benjamin Neel
2020PROFESSOR, NYU GROSSMAN SCHOOL OF MEDICINE/DIRECTOR, PERLMUTTER CANCER CENTER
COLUMBIA UNIVERSITY IRVING MEDICAL CENTER
Large-scale functional analysis of BRCA1/2 single nucleotide variants
Dr. Mark Pegram
2020SUSY YUAN-HUEY HUNG PROFESSOR OF MEDICAL ONCOLOGY
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Mechanisms of antibody-dependent cell-mediated cytotoxicity (ADCC) tolerance in HER2+ breast cancer
Dr. Liza Makowski
2020PROFESSOR, DEPARTMENT OF MEDICINE
THE UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER
PKC agonism reprograms innate immune suppression in Triple Negative Breast Cancer
Dr. Karl Willert
2020PROFESSOR, CELLULAR & MOLECULAR MEDICINE
UNIVERSITY OF CALIFORNIA SAN DIEGO
Targeted Killing of FZD7-Positive Ovarian Tumors
Dr. Zhijie (Jason) Liu
2020ASSISTANT PROFESSOR, MOLECULAR MEDICINE
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO
Targeting a non-canonical role of YAP/TEAD for breast cancer therapy
Dr. Hui Zong
2020ASSOCIATE PROFESSOR, MICROBIOLOGY, IMMUNOLOGY, & CANCER BIOLOGY
UNIVERSITY OF VIRGINIA
Optimization of dosing regimen of PARP inhibitor for BRCA1-related breast cancer prevention.
Dr. Paul Lambert
2020HOWARD M. TEMIN PROFESSOR AND CHAIR OF ONCOLOGY
UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH
Role of the Microbiome in Cervical Cancer
Dr. Richard Wang
2020ASSOCIATE PROFESSOR, DERMATOLOGY
UT SOUTHWESTERN MEDICAL CENTER
Development of a novel marker for cervical and vulvar cancers using HPV circular RNA
International Postdoctoral Scholars in Cancer Research Fellowship
Dr. Ana Martin Vega
SpainFocusing on cutting-edge research for lung cancer
Dr. Liliana Teixeira
PortugalFocusing on biophysical techniques
Dr. Natalia Bernardes
BrazilFocusing on molecules involved in DNA packaging
Dr. Sebastian Diegeler
GermanyFocusing on radiation, immunity cancer biology
Dr. Shengyan Gao
ChinaFocusing on colon cancer cell proliferation and metastasis
Dr. Hong-Yi Liu
ChinaResearch focus coming soon
Dr. Maria Del Rosario Chica Parrado
SpainResearch focus coming soon
Ms. Malini Rethnam
COMING JANUARY 2022Singapore
Research focus coming soon